Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Laboratory results can be affected by sample to sample carryover. Carryover of different analytes occurring in automated clinical chemistry, immunology, hematology, and molecular laboratories is well described. However, carryover in a transfusion service laboratory is not reported in medical literature.
Materials And Methods: Immunohematology testing results, demographic data, and clinical data were reviewed on three patients retrospectively from 2015 to 2019.
Results: Type and screen samples tested on automated gel platform from two D+ patients were affected by anti-D carryover from a patient sample with a very high-titer anti-D. Additional immunohematology and molecular testing confirmed that anti-D in samples of two D+ patients was due to carryover.
Conclusion: A case of anti-D carryover caused false detection of anti-D in two D+ patients. Carryover can have implications for patient management. Transfusion laboratory staff need to be aware of it and investigate any unexpected results further.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/trf.16578 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Emergence of additional anti-C with amplification of anti-D titer post-Rh-Kell phenotype-matched intrauterine transfusions in severe hemolytic disease of fetus.
Asian J Transfus Sci
February 2024
Department of Transfusion Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Transplacental ultrasound-guided intrauterine transfusion (IUT) acts as a lifesaving therapy to prevent fetal anemia or even to reverse fetal hydrops. IUTs are generally initiated after 22-24 weeks of gestation and repeated every 2-4-week period of gestation. Although Rh-Kell phenotype-matched, fresh irradiated leukoreduced donor-packed red cells help to increase fetal hemoglobin level, this invasive procedure can increase fetal complications by fetomaternal hemorrhage.
View Article and Find Full Text PDFA or AB? Resolving the dilemma of weaker subgroup through serological evaluation: Reporting two cases from Uttarakhand.
Asian J Transfus Sci
February 2024
Department of Transfusion Medicine and Blood Bank, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Blood group discrepancies and their resolution can sometimes become tricky when it comes to weaker subgroups. A number of weaker B subgroups, which are very infrequently encountered, have been described, including B, B, B, and B. The varied serologic reactivity of these subgroups, using routine human polyclonal antisera, usually startles the personnel involved in such blood group discrepancies and interpretation is either delayed or incorrect.
View Article and Find Full Text PDFAlloanti-D in a DBT pregnant woman responsible for hemolytic disease of the fetus and newborn: Molecular study and genetic counseling.
Transfusion
August 2025
Facultad de Ciencias Bioquímicas y Farmacéuticas, Laboratorio de Inmunohematología e Inmunogenética, IDICER - CONICET, Universidad Nacional de Rosario, Rosario, Argentina.
Background: While some partial D patients are not detected in routine D typing due to strong positive reactions with the commercially available anti-D reagents used, clinically significant alloanti-D against the absent epitopes can be produced following immunization with D-positive (D+) erythrocytes. This study aimed to characterize the allelic variant underlying the D+ phenotype in an alloimmunized, pregnant woman (anti-D titer: 64) and to provide genetic counseling to her close family members.
Materials And Methods: The proband and five family members were investigated in the study.
Alloimmunization in a Rhesus (Rh) D-Negative Pregnant Woman With an Uncommon Rh Phenotype: A Case Report.
Cureus
June 2025
Department of Community Medicine, Shri M. P. Shah Government Medical College, Jamnagar, IND.
Rhesus (Rh) alloimmunization remains a critical concern in obstetrics, particularly in RhD-negative pregnant women who have not received postpartum Rh immunoglobulin (RhIg) prophylaxis. This report describes the case of a 19-year-old pregnant woman in her second pregnancy who had no documented administration of anti-D prophylaxis after her first childbirth. During routine screening at 28 weeks of gestation, her Indirect Coombs Test (ICT) showed strong positivity (3+), with an anti-D antibody titer of 1:128.
View Article and Find Full Text PDFBackground: The safety of blood transfusion can be significantly affected by complex blood group antigens, especially the polymorphic Rh blood group system. This case study is to alert clinicians and laboratory personnel to accurately identify and manage RhD blood groups.
Methods: A Chinese female patient with cervical squamous cell carcinoma underwent surgical treatment; her blood typing identified that she had serological type A and different RhD titers to the anti-D reagent.